KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Exchange Rate Effect (2016 - 2025)

BeOne Medicines (ONC) has disclosed Exchange Rate Effect for 11 consecutive years, with $9.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect fell 65.06% to $9.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$14.9 million, a 135.13% decrease, with the full-year FY2024 number at -$51.7 million, down 539.76% from a year prior.
  • Exchange Rate Effect was $9.9 million for Q3 2025 at BeOne Medicines, down from $23.5 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $64.5 million in Q4 2022 to a low of -$80.2 million in Q2 2022.
  • A 5-year average of -$4.1 million and a median of $3.5 million in 2025 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: crashed 4247.95% in 2022, then skyrocketed 5299.62% in 2024.
  • BeOne Medicines' Exchange Rate Effect stood at $7.3 million in 2021, then skyrocketed by 788.33% to $64.5 million in 2022, then plummeted by 34.52% to $42.3 million in 2023, then crashed by 222.35% to -$51.7 million in 2024, then surged by 119.15% to $9.9 million in 2025.
  • Per Business Quant, the three most recent readings for ONC's Exchange Rate Effect are $9.9 million (Q3 2025), $23.5 million (Q2 2025), and $3.5 million (Q1 2025).